News & Trends - MedTech & Diagnostics
College of Pathologists strongly recommends to conserve lab swabs for urgent COVID-19 tests

Due to a limited supply, the Royal College of Pathologists of Australasia (RCPA) is calling for all clinicians, GPs and healthcare providers to conserve the utilisation of all lab swabs, by limiting any unnecessary or non-urgent testing, such as for chronic leg ulcers.
Dr Michael Dray, President of the Royal College of Pathologists of Australasia said, “It is essential that the use of all swabs is conserved to critical testing only. Currently, swabs should only be utilised for the testing of COVID-19 where they meet testing criteria, and for other urgent conditions.
“It is important to acknowledge that laboratories are working at high capacity during this period of increased demand, therefore, we seek the assistance of our healthcare colleagues to ensure that all tests are prioritised as much as possible.
Register FREE and join 20,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.
“Pathologists and Scientists are playing a critical role during this pandemic, as they work around the clock to deliver high-quality testing within short timeframes, whilst testing for and diagnosing COVID-19. The RCPA continues to be dedicated to ensuring that patients receive only the highest levels of care and receive the highest standards of quality testing, in order to ensure optimal patient outcomes.”
The RCPA is the leading organisation representing pathologists in Australasia and will continue to support pathologists and improve the use of pathology testing to achieve better healthcare in the community.
News & Trends - MedTech & Diagnostics

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms
Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]
MoreNews & Trends - Pharmaceuticals

Oncologists pioneer liquid biopsy-guided treatment in lung cancer
Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]
MoreMedical and Science

The high cost of record low research funding
Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]
MoreNews & Trends - Pharmaceuticals

UCB secures dermatology indication with first dual IL-17A/F inhibitor
UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]
More